Glycemic control, renal complications, and current smoking in relation to excess risk of mortality in persons with type 1 diabetes

Journal of Diabetes Science and Technology

Volumn 10, Issue 5, 2016, Pages 1006-1014

  Ahlén, Elsa ^a,b   Pivodic, Aldina ^c   Wedel, Hans ^d   Dahlqvist, Sofia ^e   Kosiborod, Mikhail ^f   Lind, Marcus ^a,e,g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Värnamo Hospital   (Sweden)

^c Statistiska Konsultgruppen   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e Department of Research and Development NU Hospital Group   (Sweden)

^f SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^g UDDEVALLA HOSPITAL   (Sweden)

Author keywords

Hypoglycemia; Ketoacidosis; Mortality; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; EDUCATIONAL STATUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLYCEMIC CONTROL; HAZARD RATIO; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTOXICATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; RISK FACTOR; SMOKING; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETIC NEPHROPATHIES; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SWEDEN;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; SWEDEN;

EID: 85013025431     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816652901     Document Type: Article

References (16)

1. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(suppl 1):S14-S80.
2. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. Available at: http://egap. evidence.nhs.uk/type-1-diabetes-cg15/guidance#blood-glucose-control-and-insulin-therapy. Accessed January 8, 2014.
3. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2013;37(suppl 1):S1-S212.
4. Livingstone SJ, Levin D, Wild SH, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313(1):37-44.
5. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972-1982.
6. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care. 2010;33(7):1640-1646.
7. Olén O, Bihagen E, Rasmussen F, Ludvigsson JF. Socioeconomic position and education in patients with coeliac disease. Dig Liver Dis. 2012;44(6):471-476.
8. Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J. 2011;32(19): 2430-2437.
9. Lind M, Odén A, Fahlén M, Eliasson B. A systematic review of HbA1c variables used in the study of diabetic complications. Diabetes Metab Syndrome. 2008;2:282-293.
10. Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40(1):78-89.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470.
12. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM, ed. Brenner and Rector's the Kidney. 7th ed. Philadelphia, PA: WB Saunders; 2004:1777-1818.
13. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med. 1999;16(6): 459-465.
14. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49(2):298-305.
15. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59(12):3216-3222.
16. Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLOS Med. 2012;9(10):e1001321.